Insiders Pluri Inc.

Equities

PLUR

US72942G2030

Delayed Nasdaq Other stock markets 04:30:00 2024-05-24 pm EDT			5-day change	1st Jan Change
6.02 ^USD	-2.43%		-1.31%	+29.85%

May. 09	Pluri Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
May. 02	Pluri Inc. Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pluri Inc. Announces Appointments to Its Scientific Advisory Board	May. 02	CI
Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board	Mar. 06	CI
Pluri Inc. Appoints Andy Lewin to Lead Business of its Contract Development and Manufacturing Organization: PluriCDMO Division	Jan. 08	CI
Pluri Inc. Announces Appointment of Lorne Abony to Board of Directors	23-07-13	CI
Pluristem Therapeutics Inc will Change its Name to Pluri Inc	22-07-26	CI
Pluristem Therapeutics Changes Name to Pluri as It Seeks Cell-based Products Beyond Medicine	22-07-25	MT
Pluristem Therapeutics Inc. has Changed its Name to Pluri Inc	22-07-25	CI
Pluristem Therapeutics Inc. Announces Board Changes	22-06-23	CI
Pluristem Therapeutics Inc. and Tnuva Group Appoint Eyal Rosenthal as Chief Executive Officer of Their New Joint Venture	22-03-08	CI
Pluristem Therapeutics Inc. Appoints Varda Shalev and Doron Birger to Join its Board of Directors	21-07-19	CI
Insider Trends: Pluristem Therapeutics Insider Extends 90-Day Selling Trend	21-06-01	MT
Insider Trends: Insider Prolongs 90-Day Selling Trend at Pluristem Therapeutics	21-05-27	MT
Insider Trends: Insider Sales Continue 90-Day Trend at Pluristem Therapeutics	21-05-04	MT
Pluristem Therapeutics Inc. Announces Board Appointments	21-01-06	CI
Insider Trends: Insider Buying Added to with Purchase of Pluristem Therapeutics Shares	20-12-01	MT
Insider Trends: Insider Buying Added to with Purchase of Pluristem Therapeutics Shares	20-11-03	MT
Pluristem Therapeutics Inc. Announces Management Changes	20-07-01	CI
Pluristem Therapeutics Inc. Announces Management Changes	19-06-24	CI
Pluristem Therapeutics, Inc. Announces Management Changes	19-03-18	CI
Pluristem Therapeutics Inc. Appoints Roger Jeffs to the Strategic Advisory Board	18-03-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Pluri Inc.

Equities

PLUR

US72942G2030

Insiders

Filters